Last reviewed · How we verify
NCT04212910
Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model
trial in Endometrium Cancer in 101 participants. Currently enrolling.
31 December 2025
Quick facts
| Lead sponsor | IRCCS San Raffaele |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 101 |
| Start date | 23 July 2019 |
| Primary completion | 31 December 2025 |
| Estimated completion | 28 February 2027 |
| Sites | 1 location across Italy |
Conditions studied
- Endometrium Cancer — all drugs for Endometrium Cancer →
Sponsor
IRCCS San Raffaele — full company profile →
Who can join
18 and older, female only, with Endometrium Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Endometrial cancer (EC) is the most common gynecological malignancy in high-income countries. Prognosis and treatment are dictated by cancer histological subtype and grade coupled with surgical staging as described by Surgical International Federation of Gynecology and Obstetrics (FIGO) staging system. Surgery is the elective standard treatment and used for staging of EC. The purpose of this study is to collect images from a simultaneous PET/MRI study from which to extrapolate a preoperative, non-invasive, prognostic model.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Current Update on PET/MRI in Gynecological Malignancies-A Review of the Literature.
Virarkar M, Vulasala SS, Calimano-Ramirez L, Singh A, et al · · 2023 · cited 5× · PMID 36661732 · DOI 10.3390/curroncol30010083 -
[<sup>18</sup>F]FDG PET/MRI in Endometrial Cancer: Prospective Evaluation of Preoperative Staging, Molecular Characterization and Prognostic Assessment.
Bezzi C, Ironi G, Russo T, Candotti G, et al · · 2026 · PMID 41595203 · DOI 10.3390/cancers18020280
Verify or expand the search:
- PubMed search for NCT04212910
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Endometrium Cancer
Currently open trials in the same condition.
- NCT07503808 — A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types · Phase 1 · recruiting
- NCT07318727 — Comparative Study on the Effect of Diet Interventions on Weight Loss in Overweight Endometrial Cancer Patients Undergoin · NA · recruiting
- NCT06841653 — A.I and Machine Learning Based Risk Prediction Model to Improve the Clinical Management of Endometrial Cancer. · recruiting
- NCT06169449 — Weight Management in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment · NA · recruiting
- NCT04014530 — Pembrolizumab With Ataluren in Patients With Metastatic pMMR and dMMR Colorectal Carcinoma or Metastatic dMMR Endometria · Phase 1, PHASE2 · recruiting
Other IRCCS San Raffaele trials
Trials by the same sponsor.
- NCT07454759 — Acute Sarcopenia in Hospitalized Older Adults · not yet recruiting
- NCT07456462 — Making Antibody Treatments More Effective in Early Alzheimer's Disease Using 3Tesla Magnetica Resonance · NA · not yet recruiting
- NCT07066878 — This Protocol Focuses on the Factors That Influence Survival, the Development of Complications and the Quality of Life B · not yet recruiting
- NCT07526298 — Anticipating Irreversible Disability in Neuromyelitis Optica Spectrum Disorder: a Study to Assess Disease Activity in Ap · not yet recruiting
- NCT07426471 — Delafloxacin Plasma and Tissue Concentration in Patients With Skin, Soft Tissue, and Bone and Joint Infections. · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04212910 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IRCCS San Raffaele
- Last refreshed: 12 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04212910.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing